Article Name Predictive Diagnostics
“The interest of companies in biobanks has significantly increased but investments have not yet been realised”
BioBank Japan, a hospital-based multi-institutional biobank that has collected DNA, serum and medical record information from ~260,000 patients affected by one of 51 pre-defined diseases, is now launching a new phase to accelerate precision medicine and health in Japan. In an address on May 24 in Tokyo, Professor Yoichiro Kamatani, a member of the Steering Committee at BioBank Japan, presented the new phase and future direction of this important biobank for the future health of Japan. In an interaction with BioSpectrum Asia, Prof. Kamatani reveals more details about the work being done at BioBank Japan.
07th July, 2023
Alma, Sisram Medical's Acquisition of PhotonMed, Establishes Direct Operation in China
Alma, the world leader and innovator in providing energy-based medical and aesthetic solutions and a wholly-owned company by Sisram Medical (1696.HK), announced that it has completed the acquisition of PhotonMed International Ltd ("PhotonMed"), the leading Chinese distributor of energy-based devices, and is establishing a direct operation in mainland China.
04th July, 2023
BioVigil Unveils AccuWashTM for Precise Hand Hygiene Tracking in Healthcare and Beyond
AccuWashTM Technology monitors and aids an engaged hand wash; helps reduce C. diff, HAIs.
27th June, 2023
Medtech Special
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer